The Future of Drug Discovery is 3D

Improving the identification and validation of disease-specific drug targets in a cell-type and patient-specific manner early on will not only reduce the failure rate and cost that is so inherent in current drug development processes but also allow the development of more effective precision medicines, improving patient outcomes. The post The Future of Drug Discovery…

Read More

The Outlook for PEPFAR in 2025 and Beyond

PEPFAR, the U.S. global HIV/AIDS program, is – for the first time in its two-decade history – facing significant challenges that could impede its ability to fulfill its mission. This policy brief provides an overview of recent events and ongoing challenges facing the program.

Read More

Improving the patient experience – why it matters

No matter how much the healthcare industry evolves — whether through new legislative priorities or advances in AI and automation — one thing remains constant: the patient experience matters. Patients expect quality care, quickly. For five years running, timely access has been a top priority for patients, according to Experian Health’s State of Patient Access…

Read More

Attention Healthcare and Life Science Startups: Deadline for INVEST Pitch Perfect Contest Submissions is Feb 21

We’re looking for biopharma startups focused on infectious diseases, medtech/diagnostics startups supporting chronic disease management, and health tech startups seeking to improve care navigation and coordination and developing AI tech. The post Attention Healthcare and Life Science Startups: Deadline for INVEST Pitch Perfect Contest Submissions is Feb 21 appeared first on MedCity News.

Read More

Key Facts About Hospitals

This analysis presents key facts about hospitals with more than 40 charts related to national spending on hospital care, characteristics of the hospital industry, rural hospitals, use of hospital care, out-of-pocket spending and medical debt, hospital prices, hospital finances, and charity care.

Read More